|
|
Blood, 15 January 2007, Vol. 109, No. 2, pp. 653-660.
Prepublished online as a Blood First Edition Paper on September 28, 2006; DOI 10.1182/blood-2006-04-017368.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Apoptotic cells induce Mer tyrosine kinasedependent blockade of NF- B activation in dendritic cells
Pradip Sen1,
Mark A. Wallet1,
Zuoan Yi1,
Yingsu Huang1,
Michael Henderson1,
Clayton E. Mathews2,
H. Shelton Earp3,4,
Glenn Matsushima1,3,5,
Albert S. Baldwin, Jr3,6, and
Roland M. Tisch1,3,
1 Department of Microbiology and Immunology,
3 University of North Carolina (UNC) Lineberger Comprehensive Cancer Center,
4 Department of Medicine and Pharmacology,
5 UNC Neuroscience Center, and
6 Department of Biology, University of North Carolina at Chapel Hill;
2 Department of Pediatrics, University of Pittsburgh, PA
Dendritic cells (DCs) play a key role in immune homeostasis and maintenance of self-tolerance. Tolerogenic DCs can be established by an encounter with apoptotic cells (ACs) and subsequent inhibition of maturation and effector functions. The receptor(s) and signaling pathway(s) involved in AC-induced inhibition of DCs have yet to be defined. We demonstrate that pretreatment with apoptotic but not necrotic cells inhibits activation of I B kinase (IKK) and downstream NF- B. Notably, receptor tyrosine kinase Mer (MerTK) binding of ACs is required for mediating this effect. Monocyte-derived DCs lacking MerTK expression (MerTKKD) or treated with blocking MerTK-specific antibodies (Abs) are resistant to AC-induced inhibition and continue to activate NF- B and secrete proinflammatory cytokines. Blocking MerTK activation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway prevents AC-induced inhibition. These results demonstrate an essential role for MerTK-mediated regulation of the PI3K/AKT and NF- B pathways in AC-induced inhibition of monocyte-derived DCs.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Ait-Oufella, V. Pouresmail, T. Simon, O. Blanc-Brude, K. Kinugawa, R. Merval, G. Offenstadt, G. Leseche, P. L. Cohen, A. Tedgui, et al.
Defective Mer Receptor Tyrosine Kinase Signaling in Bone Marrow Cells Promotes Apoptotic Cell Accumulation and Accelerates Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2008;
28(8):
1429 - 1431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tibrewal, Y. Wu, V. D'mello, R. Akakura, T. C. George, B. Varnum, and R. B. Birge
Autophosphorylation Docking Site Tyr-867 in Mer Receptor Tyrosine Kinase Allows for Dissociation of Multiple Signaling Pathways for Phagocytosis of Apoptotic Cells and Down-modulation of Lipopolysaccharide-inducible NF-{kappa}B Transcriptional Activation
J. Biol. Chem.,
February 8, 2008;
283(6):
3618 - 3627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-Q. Xia, R. Peng, Y. Qiu, M. Annamalai, D. Gordon, and M. J. Clare-Salzler
Transfusion of Apoptotic {beta}-Cells Induces Immune Tolerance to {beta}-Cell Antigens and Prevents Type 1 Diabetes in NOD Mice
Diabetes,
August 1, 2007;
56(8):
2116 - 2123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |